Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 25 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Lola M.

New Zealand

USD 25 /hr

Molecular biologist with experience in scientific/academic writing and quantitative data analysis

Profile Summary

I am a molecular biologist with a PhD in Biomedical Science (The University of Auckland) for which I was placed on the Dean’s List for PhD Excellence. I have 8+ years of experience in scientific writing and biostatistics. Having supervised over 15 students to date, I have gained extensive experience in editing and proof-reading medical, academic, and scientific documents. I also have an outstanding grant success record of over 80%. I have accrued 34 publications and 6 patents to date with 900 citations and an H index of 15 (Google Scholar). My areas of expertise include cell and molecular biology, review of scientific literature (manuscripts and grant proposals), quantitative statistical analysis, methodology development, as well as data interpretation and analysis.

Subject Matter Expertise

• ★ Molecular Biology
• ★ Ophthalmology
• ★ Inflammation
• ☆ Zoology
• ☆ Animal Science
• ☆ Biomarkers
• ☆ Neuroscience
• ☆ Statistics
• ☆ Excel
• ☆ Medical Sciences

Services

• Writing
• Research
• Data & AI
• Product Development

Writing Medical Writing, Technical Writing, Copywriting, Newswriting, General Proofreading & Editing

Research Market Research

Data & AI Statistical Analysis, Data Visualization, Big Data Analytics

Product Development Product Evaluation, Product Validation

Work Experience

Deputy Director

Buchanan Ocular Therapeutics Unit

December 2020 - Present

Postdoctoral Research Fellow

University of Auckland

June 2018 - Present

Research Technician

University of Auckland

March 2018 - April 2018

Education

PhD (Biomedical Sciences) (Ophthalmology)

University of Auckland

March 2015 - February 2018

MSc (Hons) (Centre of Brain Research)

University of Auckland

2014 - 2014

BSc (Biomedical Science) (School of Medical Sciences)

University of Auckland

2010 - 2012

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Kuo CYJ, Louie HH, Rupenthal ID, Mugisho OO(2021). Characterization of a Novel Human Organotypic Retinal Culture Technique . Journal of visualized experiments : JoVE.

Marasini S, Mugisho OO, Swift S, Read H, Rupenthal ID, Dean SJ, Craig JP(2021). Effect of therapeutic UVC on corneal DNA: Safety assessment for potential keratitis treatment . The ocular surface.

(2021). Connexin therapeutics: blocking connexin hemichannel pores is distinct from blocking pannexin channels or gap junctions . Neural Regeneration Research.

Louie HH, Shome A, Kuo CY, Rupenthal ID, Green CR, Mugisho OO(2020). Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathy . Experimental eye research.

Lyon H, Shome A, Rupenthal ID, Green CR, Mugisho OO(2020). Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy . International journal of molecular sciences.

Agban Y, Mugisho OO, Thakur SS, Rupenthal ID(2020). Characterization of Zinc Oxide Nanoparticle Cross-Linked Collagen Hydrogels . Gels (Basel, Switzerland).

Kang H, Yin N, Lyon H, Rupenthal ID, Thakur SS, Mugisho OO(2020). The influence of hyperglycemia on the safety of ultrasound in retinal pigment epithelial cells . Cell biology international.

Mugisho OO, Robilliard LD, Nicholson LFB, Graham ES, O'Carroll SJ(2019). Bradykinin receptor-1 activation induces inflammation and increases the permeability of human brain microvascular endothelial cells . Cell biology international.

Mugisho OO, Rupenthal ID, Paquet-Durand F, Acosta ML, Green CR(2019). Targeting connexin hemichannels to control the inflammasome: the correlation between connexin43 and NLRP3 expression in chronic eye disease . Expert opinion on therapeutic targets.

Kuo, C., Green, C.R., Rupenthal, I.D., Mugisho, O.O.(2019). Connexin43 hemichannel block protects against retinal pigment epithelial cell barrier breakdown . Acta Diabetologica.

Mugisho, O.O., Green, C.R., Zhang, J., Acosta, M.L., Rupenthal, I.D.(2019). Connexin43 hemichannels: A potential drug target for the treatment of diabetic retinopathy . Drug Discovery Today. 24. (8). p. 1627-1636.

Agban, Y., Thakur, S.S., Mugisho, O.O., Rupenthal, I.D.(2019). Depot formulations to sustain periocular drug delivery to the posterior eye segment . Drug Discovery Today. 24. (8). p. 1458-1469.

Mugisho, O.O., Green, C.R., Squirrell, D.M., Bould, S., Danesh-Meyer, H.V., Zhang, J., Acosta, M.L., Rupenthal, I.D.(2019). Connexin43 hemichannel block protects against the development of diabetic retinopathy signs in a mouse model of the disease . Journal of Molecular Medicine. 97. (2). p. 215-229.

Mugisho, O.O., Rupenthal, I.D., Squirrell, D.M., Bould, S.J., Danesh-Meyer, H.V., Zhang, J., Green, C.R., Acosta, M.L.(2018). Intravitreal pro-inflammatory cytokines in non-obese diabetic mice: Modelling signs of diabetic retinopathy . PLoS ONE. 13. (8).

Mugisho, O.O., Green, C.R., Kho, D.T., Zhang, J., Graham, E.S., Acosta, M.L., Rupenthal, I.D.(2018). The inflammasome pathway is amplified and perpetuated in an autocrine manner through connexin43 hemichannel mediated ATP release . Biochimica et Biophysica Acta - General Subjects. 1862. (3). p. 385-393.

Mugisho, O.O., Green, C.R., Zhang, J., Binz, N., Acosta, M.L., Rakoczy, E., Rupenthal, I.D.(2017). Immunohistochemical characterization of connexin43 expression in a mouse model of diabetic retinopathy and in human donor retinas . International Journal of Molecular Sciences. 18. (12).

Nicholson, L.F.B., Choi, J.M., Rotimi, O.O., O'Carroll, S.J.(2016). IL-6 stimulates a concentration-dependent increase in MCP-1 in immortalised human brain endothelial cells . F1000Research. 5.

O'Carroll, S.J., Kho, D.T., Wiltshire, R., Nelson, V., Rotimi, O., Johnson, R., Angel, C.E., Graham, E.S.(2015). Pro-inflammatory TNFaα and IL-1β differentially regulate the inflammatory phenotype of brain microvascular endothelial cells . Journal of Neuroinflammation. 12. (1).